bevacizumab,paclitaxel,durvalumab,atezolizumab,gemcitabine,cisplatin
astrazeneca,roche
[]
dr. el dika discussant on swog 1815 and imbrave 151, more is not always better in adv btc #gi23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope